Table 1 Overview about HER2 fluorescence in situ hybridization thresholds for dual-color assays assessing HER2 and CEP17 gene copy number

From: Impact of updated HER2 testing guidelines in breast cancer—re-evaluation of HERA trial fluorescence in situ hybridization data

 

PathVysion package insert

ASCO/CAP 2007 (ref. 9)

ASCO/CAP 2013 (ref. 10)

HER2 gene amplification

HER2/CEP17 ratio ≥2.0

HER2/CEP17 ratio >2.2

HER2/CEP17≥2.0 or HER2/CEP17<2.0 and mean HER2 gene copy number ≥6.0

Equivocal

Not applicable

HER2/CEP17 ratio of 1.8–2.2

HER2/CEP17<2.0 and mean HER2 gene copy number ≥4.0 and<6.0

No HER2 gene amplification

HER2/CEP17<2.0

HER2/CEP17 ratio <1.8

HER2/CEP17<2.0 and mean HER2 gene copy number <4.0